Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Aclaris Therapeutics
ACRS
$851M
| $12.8M | 0.01% |
882,364
+14,134
| +2% | +$242K |
|
1727
Fate Therapeutics
FATE
$300M
| $12.8M | 0.01% |
785,246
+677,366
| +628% | +$8.01M |
|
|
DATA
1728
DELISTED
Tableau Software, Inc.
DATA
| $12.8M | 0.01% |
114,365
+100,005
| +696% | +$10.8M |
|
1729
Lamb Weston
LW
$7.3B
| $12.8M | 0.01% |
191,480
-714,046
| -79% | -$49M |
|
1730
PUT
Credit Acceptance
CACC
$6.1B
| $12.7M | 0.01% |
29,100
+9,300
| +47% | +$3.9M |
|
1731
Designer Brands
DBI
$299M
| $12.7M | 0.01% |
376,118
+88,493
| +31% | +$2.59M |
|
1732
PUT
Itaú Unibanco
ITUB
$81.6B
| $12.7M | 0.01% |
2,392,776
+952,617
| +66% | +$5.12M |
|
1733
CALL
Tractor Supply
TSCO
$18.7B
| $12.7M | 0.01% |
701,000
+176,000
| +34% | +$2.93M |
|
1734
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $12.7M | 0.01% |
103,500
+44,900
| +77% | +$5.09M |
|
1735
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $12.7M | 0.01% |
144,682
+85,677
| +145% | +$7.37M |
|
1736
MetLife
MET
$62.1B
| $12.7M | 0.01% |
271,330
+243,013
| +858% | +$11.1M |
|
|
CZR
1737
DELISTED
Caesars Entertainment Corporation
CZR
| $12.7M | 0.01% |
1,235,962
-375,846
| -23% | -$3.95M |
|
|
BBBY
1738
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $12.7M | 0.01% |
843,600
+257,900
| +44% | +$4.83M |
|
1739
PUT
Tyson Foods
TSN
$20.5B
| $12.6M | 0.01% |
212,300
-134,900
| -39% | -$8.44M |
|
1740
CALL
Match Group
MTCH
$8.71B
| $12.6M | 0.01% |
218,100
-486,600
| -69% | -$22.8M |
|
1741
PUT
Madison Square Garden
MSGS
$9.8B
| $12.6M | 0.01% |
56,080
+140
| +0.3% | +$31.1K |
|
1742
PUT
Harley-Davidson
HOG
$2.89B
| $12.6M | 0.01% |
278,200
-90,900
| -25% | -$3.95M |
|
1743
PUT
DaVita
DVA
$11.5B
| $12.6M | 0.01% |
175,800
+48,400
| +38% | +$3.42M |
|
1744
CALL
FTAI Aviation
FTAI
$22.3B
| $12.6M | 0.01% |
+810,683
| New | +$12.8M |
|
1745
Omeros
OMER
$1.24B
| $12.6M | 0.01% |
+515,279
| New | +$11.5M |
|
1746
Manitowoc
MTW
$746M
| $12.6M | 0.01% |
524,030
+161,324
| +44% | +$3.95M |
|
|
PINC
1747
DELISTED
Premier
PINC
| $12.6M | 0.01% |
274,531
-46,964
| -15% | -$1.9M |
|
1748
Jones Lang LaSalle
JLL
$17.3B
| $12.6M | 0.01% |
87,062
+83,349
| +2,245% | +$13.1M |
|
|
GCP
1749
DELISTED
GCP Applied Technologies Inc.
GCP
| $12.6M | 0.01% |
472,861
+178,280
| +61% | +$4.82M |
|
1750
CALL
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
| $12.5M | 0.01% |
216,500
-153,100
| -41% | -$8.4M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.